Pharmaceutical composition comprising at least one anticancer drug and at least one polymer

Details for Australian Patent Application No. 2006324872 (hide)

Owner Panacea Biotec Limited

Inventors Gupta, Ajay K.; Singh, Amarjit; Kulkarni, Mangesh M.; Singh, Sarabjit

Agent Watermark

Pub. Number AU-B-2006324872

PCT Pub. Number WO2007/069272

Priority 1327/MUM/2005 21.10.05 IN; 1081/MUM/2006 10.07.06 IN

Filing date 19 October 2006

Wipo publication date 21 June 2007

Acceptance publication date 8 March 2012

International Classifications

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/069272 Priority application(s): WO2007/069272

8 March 2012 Application Accepted

  Published as AU-B-2006324872

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006324920-Method and system for usage of block cipher encryption

2006324854-Polymorphs and amorphous forms of 5-amino-l-[2,6dichloro4-(trifluoromethyl)phenyl]-4- [(trifluoromethyl)sulfinyl]-IH-pyrazole-3carbonitrile